Today’s pulse
This cycle has one quiet protagonist: inflammaging, the chronic, low-grade inflammation that accumulates as the body ages. Four of today's findings are views of the same fire from different angles: Klotho restrains it and tracks slower biological aging, artificial light at night stokes it in the airway and the artery, fermented foods damp it across nineteen cytokines, and a longitudinal epigenetic clock reads its cumulative toll well enough to predict death. The through-line is that inflammaging is not a vague backdrop, it is measurable, modifiable, and networked.
Pillar 1. Clinical Metabolomics
No notable signal this cycle.
No notable signal in Clinical Metabolomics this cycle. The Longevity Consortium's aging-metabolome map anchored yesterday's issue, and nothing new and verifiable surfaced inside this window. The metabolomic correlates of inflammaging (e.g., the lipid-saturation and tryptophan shifts noted previously) remain the relevant reference point.
Why it matters for optimization: Cross-pillar coverage keeps the daily read honest; today's metabolomic story is doing visible work in the through-line rather than as a siloed headline.
Editor's note →Pillar 2. Evolutionary Medicine
More Klotho, slower clock: the anti-mTOR longevity protein, measured at population scale.
A study in PLOS One (March 2, 2026) analyzed 5,654 NHANES participants aged 45-85, quantifying serum Klotho by ELISA and biological-age acceleration (BAA) via the BioAge package. Higher Klotho was robustly and independently associated with less accelerated aging across every model (odds of accelerated aging down to ~0.62), with a non-linear L-shaped dose-response suggesting a protective threshold, and stronger effects in women, those over 60, and people without chronic illness. Klotho is the evolutionarily conserved protein that restrains insulin/IGF-1-mTOR signaling and tempers inflammaging and the senescent secretory phenotype, squarely the anabolic/catabolic balance HOMe targets. This is the unifying-framework pillar putting a population number on a mechanism the field has mostly studied in cells and mice.
Why it matters for optimization: Klotho is a candidate optimal-range biomarker for the anabolic-axis side of the A+B+C equation, and a rationale for interventions (exercise, mTOR restraint) known to raise it.
PLOS One, March 2026 →Pillar 3. Chronobiology
Light at night, asthma, and a clock gene named TIMELESS.
A multi-method study in Frontiers in Pediatrics (April 23, 2026) linked artificial light at night (ALAN) to childhood asthma, combining urban epidemiology in China, a pediatric clinical cohort, Mendelian randomization, and multi-omics. Excessive nighttime light correlated tightly with circadian disruption (R = 0.756), Mendelian randomization supported a causal path from circadian disruption to asthma, and the circadian clock gene TIMELESS emerged as a key regulator, highly expressed in asthmatic airway epithelium, and whose knockdown reduced epithelial proliferation. This is the environmental-timekeeper pillar showing a clock gene mechanistically wired into an inflammatory airway disease, with a modifiable exposure (light) at the top. It also reframes "asthma" as partly a circadian-immune disorder.
Why it matters for optimization: It makes nighttime light a measurable, modifiable input to immune-inflammatory disease, not just a sleep nuisance, with a named molecular handle.
Frontiers in Pediatrics, April 2026 →Pillar 4. Exposomics
Night light and dirty air don't just add up, they multiply.
A longitudinal analysis of the China Health and Retirement Longitudinal Study (CHARLS) in PLOS One (March 5, 2026) found significant interaction effects between annual change in artificial light at night and PM2.5 air pollution on cardiovascular disease in middle-aged and older adults, raising odds of hypertension (OR 1.32), heart disease (OR 1.24), and stroke (OR 1.18) beyond either exposure alone. Depressive symptoms and cognitive impairment mediated 18.7% and 12.3% of the CVD risk respectively, and women and those over 75 were most vulnerable. This is the toxin-map pillar demonstrating that the exposome behaves combinatorially: two urbanization-driven stressors synergize rather than sum. It also ties the exposome directly to the circadian pillar above, the same light-at-night lever, a different organ system.
Why it matters for optimization: Real exposure is a cocktail; reducing one stressor (night light) may yield outsized benefit precisely because it dismantles a synergy, not just a single hit.
PLOS One, March 2026 →Pillar 5. Mitochondrial Bioenergetics
No notable signal this cycle.
No notable signal in Mitochondrial Bioenergetics this cycle that clears the bar for a fresh, verifiable human finding. Recent NAD+ and urolithin A trials anchored the prior three issues; this window's mitochondrial entries were reviews or secondary reports rather than new primary human data. The mitochondrion is nonetheless implicated in today's through-line as the cell's inflammaging sensor.
Why it matters for optimization: Cross-pillar coverage keeps the daily read honest; the mitochondrion is doing visible work as the inflammaging sensor under today's findings, even without a siloed headline.
Editor's note →Pillar 6. Gut-Immune System
Fermented foods quiet nineteen inflammatory signals, fiber alone didn't.
A citizen-science randomized controlled trial (medRxiv, 2025; widely reported in late May 2026) assigned 147 healthy adults to an eight-week high-fiber or high-fermented-food diet, profiling gut microbiota, immune function, transit time, and sleep. The fermented-food arm was associated with reduced systemic inflammation, nineteen serum cytokines fell, while the high-fiber arm did not produce the same short-term anti-inflammatory shift, echoing earlier Stanford work. The result reinforces that the category of microbiome intervention matters: fermented foods deliver live microbes and their metabolites, not just substrate. This is the holobiont pillar showing a dietary lever that measurably lowers the inflammaging signal at the level of circulating cytokines. (As a preprint, treat effect sizes as provisional pending peer review.)
Why it matters for optimization: It is a concrete, food-first (probiotic-tier) intervention with a measurable inflammatory readout, exactly the bioidentical-before-xenobiotic ordering HOMe prefers.
medRxiv preprint, 2025 (May 2026 reporting) →Pillar 7. Epigenetics
It's the clock's acceleration, not its reading, that forecasts death.
A longitudinal analysis of the InCHIANTI cohort in Nature Aging (March 13, 2026) evaluated whether the rate of change of multiple epigenetic clocks, not a single snapshot, predicts mortality. Faster increases across several clocks were associated with higher risk of death, independent of baseline epigenetic age and other confounders. This is an important complement to yesterday's MACRO-trial caution: while short-term clock change didn't track metabolic improvement in a weight-loss study, longitudinal acceleration over years does carry genuine mortality signal. The dynamic-gene-regulator pillar is converging on a practical rule, measure the clock repeatedly and watch the slope, not the point.
Why it matters for optimization: It validates serial epigenetic testing (trajectory over time) as a mortality-relevant endpoint, while cautioning against over-reading any single measurement.
Nature Aging, March 2026 →The through-line
One network, seven angles
Inflammaging is the connective tissue of this issue. Klotho (Pillar 2) is an endogenous brake on the inflammatory, mTOR-driven side of aging, and more of it tracks a slower biological clock. Artificial light at night drives circadian-immune inflammation into the airway (Pillar 3) and, multiplying with air pollution, into the cardiovascular system (Pillar 4), the same modifiable exposure lighting two different fires. Fermented foods measurably lower the inflammatory signal across nineteen cytokines (Pillar 6), and the longitudinal epigenetic clock (Pillar 7) integrates this cumulative inflammatory-metabolic burden into a slope that predicts death. Environment and circadian timing feed inflammaging; the gut holobiont and Klotho restrain it; the clock keeps the score.
Practitioner’s move
What to do today
Treat inflammaging as a measurable target with named levers. Make nighttime-light hygiene a clinical prescription, not a wellness aside, blackout sleep environments, dim warm evening light, screen curfews, framing it (accurately) as cardiovascular and immune risk reduction, especially for women and older patients. Add fermented foods as a first-line, food-based anti-inflammatory intervention, and track the response with serial measurements: inflammatory markers (hs-CRP, IL-6) plus a repeated epigenetic clock read for the trajectory, since it's the slope, not the single value, that carries the mortality signal.